Literature DB >> 7762430

Lactoferrin gene promoter in human and mouse. Analogous and dissimilar characteristics.

C T Teng1.   

Abstract

Lactoferrin promoter and the 5'-flanking region of both human and mouse were isolated from a genomic library constructed with lambda phage. A 2.0 kbp Sac I fragment of the human clone (HLF031a.30) and a 3.0 kbp Eco R I/Hinc II fragment of the mouse clone (mL14p9E) containing the lactoferrin promoter, 5'-flanking region, first exon and partial intron were sequenced completely. There were many sequence homologies between human and mouse at the promoter/enhancer (1 to -363) region, yet substantial divergence was observed beyond this region. To determine the promoter activity, 5'-deletion mutants of the mouse lactoferrin gene were linked to a CAT-reporter plasmid and transfected into the human endometrium carcinoma cell line, RL95-2. We identified a number of positive and negative regulatory sequences as well as the estrogen-response element in the 5'-flanking region of the lactoferrin gene. The imperfect estrogen response elements of both human and mouse are functional as demonstrated by transfection experiments, band-shift assay and DNase I footprint analysis. The molecular mechanism that governs the estrogen-stimulated response, however, differs between human and mouse.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7762430     DOI: 10.1007/978-1-4615-2548-6_18

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  2 in total

Review 1.  Structure and biological actions of lactoferrin.

Authors:  J H Nuijens; P H van Berkel; F L Schanbacher
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-07       Impact factor: 2.673

2.  Induction of lactoferrin gene expression by innate immune stimuli in mouse mammary epithelial HC-11 cells.

Authors:  Yin Li; Gino V Limmon; Farhad Imani; Christina Teng
Journal:  Biochimie       Date:  2008-05-15       Impact factor: 4.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.